Correlation Between IShares Canadian and Knight Therapeutics

Can any of the company-specific risk be diversified away by investing in both IShares Canadian and Knight Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Canadian and Knight Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between iShares Canadian HYBrid and Knight Therapeutics, you can compare the effects of market volatilities on IShares Canadian and Knight Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Canadian with a short position of Knight Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Canadian and Knight Therapeutics.

Diversification Opportunities for IShares Canadian and Knight Therapeutics

0.61

Correlation Coefficient

IShares Canadian  Knight Therapeutics

Poor diversification

The 3 months correlation between IShares and Knight is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding iShares Canadian HYBrid and Knight Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Knight Therapeutics and IShares Canadian is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Canadian HYBrid are associated (or correlated) with Knight Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Knight Therapeutics has no effect on the direction of IShares Canadian i.e., IShares Canadian and Knight Therapeutics go up and down completely randomly.

Pair Corralation between IShares Canadian and Knight Therapeutics

Assuming the 90 days trading horizon IShares Canadian is expected to generate 10.67 times less return on investment than Knight Therapeutics. But when comparing it to its historical volatility, iShares Canadian HYBrid is 6.67 times less risky than Knight Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Knight Therapeutics is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  525.00  in Knight Therapeutics on December 30, 2024 and sell it today you would earn a total of  84.00  from holding Knight Therapeutics or generate 16.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

iShares Canadian HYBrid  vs.  Knight Therapeutics

iShares Canadian HYBrid

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in iShares Canadian HYBrid are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy fundamental drivers, IShares Canadian is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Knight Therapeutics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Knight Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, Knight Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with IShares Canadian and Knight Therapeutics

The main advantage of trading using opposite IShares Canadian and Knight Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Canadian position performs unexpectedly, Knight Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Knight Therapeutics will offset losses from the drop in Knight Therapeutics' long position.

The idea behind iShares Canadian HYBrid and Knight Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .